These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 195293)

  • 1. The Coronary Drug Project: implications for clinical care.
    Wenger NK; Stamler J
    Prim Care; 1977 Jun; 4(2):247-53. PubMed ID: 195293
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum lipid-lowering drugs following myocardial infarction].
    Schettler G
    Dtsch Med Wochenschr; 1975 Aug; 100(31):1611-2. PubMed ID: 168052
    [No Abstract]   [Full Text] [Related]  

  • 3. The coronary drug project. Findings leading to further modifications of its protocol with respect to dextrothyroxine. The coronary drug project research group.
    JAMA; 1972 May; 220(7):996-1008. PubMed ID: 4337170
    [No Abstract]   [Full Text] [Related]  

  • 4. [Role of magnesium, potassium, antikaliuretic agents and hypocholesteremic agents in cardiac lesion development in rats fed a thrombogenic diet and Na 2 HPO 4 ].
    Savoie LL
    Pathol Biol (Paris); 1972 Oct; 20(19):751-6. PubMed ID: 4343433
    [No Abstract]   [Full Text] [Related]  

  • 5. The coronary drug project--findings with regard to estrogen, dextrothyroxine, clofibrate and niacin.
    Stamler J
    Adv Exp Med Biol; 1977; 82():52-75. PubMed ID: 335823
    [No Abstract]   [Full Text] [Related]  

  • 6. The Coronary Drug Project. Initial findings leading to modifications of its research protocol.
    JAMA; 1970 Nov; 214(7):1303-13. PubMed ID: 4320008
    [No Abstract]   [Full Text] [Related]  

  • 7. [Undesirable effects of hypolipemic drugs].
    Schettler G
    Clin Ter; 1980 Mar; 92(5):457-67. PubMed ID: 7449323
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatable risk factors--hypercholesterolemia, smoking, and hypertension--after myocardial infarction: implications of the coronary drug project data for clinical management. Coronary Drug Project Research Group.
    Prim Care; 1980 Mar; 7(1):175-9. PubMed ID: 6992178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Coronary Drug Project. Findings leading to discontinuation of the 2.5-mg day estrogen group. The coronary Drug Project Research Group.
    JAMA; 1973 Nov; 226(6):652-7. PubMed ID: 4356847
    [No Abstract]   [Full Text] [Related]  

  • 10. [Results of the Coronary Drug Project--routine treatment of infarct patients with serum lipid reductants].
    Carlson LA; Rössner S
    Lakartidningen; 1975 Apr; 72(15):1549-51. PubMed ID: 1094207
    [No Abstract]   [Full Text] [Related]  

  • 11. Dextrothyroxine for lowering cholesterol.
    Med Lett Drugs Ther; 1976 Jun; 18(13):53. PubMed ID: 934018
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of clofibrate and anovulatory drugs on biliary lipid composition and bile acid kinetics.
    Pertsemlidis D; Panveliwalla D; Kimball A
    Surg Forum; 1973; 24():411-12. PubMed ID: 4377038
    [No Abstract]   [Full Text] [Related]  

  • 13. [Value of lipid lowering drugs after myocardial infarction: results of the coronary drug project 1975 (author's transl)].
    Dubach UC
    Schweiz Rundsch Med Prax; 1975 Sep; 64(37):1167-8. PubMed ID: 1219703
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of coronary heart disease with diet and lipid-reducing agents].
    Sailer D; Kolb S
    Fortschr Med; 1982 Nov; 100(43):2005-10. PubMed ID: 7152437
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diet and drug therapy of hyperlipoproteinemia].
    Sirtori C
    Minerva Med; 1975 Nov; 66(79):4184-5. PubMed ID: 1196507
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug treatment of hyperlipidemia.
    Berkowitz D
    Mod Treat; 1969 Nov; 6(6):1341-51. PubMed ID: 5377637
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hypolipidaemic agents (author's transl)].
    Tillement JP; Albengres E; Choisy H; Millart H
    Nouv Presse Med; 1980 Oct; 9(40):2947-50. PubMed ID: 7443428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The coronary drug project. Design, methods, and baseline results.
    Circulation; 1973 Mar; 47(3 Suppl):I1-50. PubMed ID: 4570454
    [No Abstract]   [Full Text] [Related]  

  • 19. [The management of hyperlipoproteinemia with Liproreduct].
    Fenster R
    Ther Ggw; 1974 May; 113(5):813-24. PubMed ID: 4603893
    [No Abstract]   [Full Text] [Related]  

  • 20. Secondary prevention of myocardial infarction with drugs.
    Klimt CR; Forman SA
    Isr J Med Sci; 1983 May; 19(5):460-70. PubMed ID: 6134697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.